Presentation Information

[O4-05]Multifaceted dual-target antiviral activity of sparfloxacin suppresses respiratory syncytial virus replication in vitro and in vivo.

*Noriko Ogasawara1,2, Soh Yamamoto1, Yuka Tanimukai2,6, Yurie Yoshida2,1, Akihiko Sato3,4,5, Hirofumi Sawa4,5, Yasuko Orba4,5, Keitaro Yoshida1, Kenichi Takano2, Shin-ichi Yokota1 (1. Division of Microbiology, Department of Infectious Diseases, Sapporo Medical University School of Medicine, 2. Department of Otolaryngology-Head and Neck Surgery, Sapporo Medical University School of Medicine, 3. Laboratory for Drug Discovery & Disease Research, Shionogi & Co., Ltd., 4. International Institute for Zoonosis Control, Hokkaido University, 5. Institute for Vaccine Research and Development, Hokkaido University, 6. Department of Otolaryngology, Obihiro Kosei Hospital)

Password required to view